According to a new report by Polaris Market Research, the U.S. liquid embolic agent market was valued at USD 66.28 million in 2024 and is projected to reach USD 156.91 million by 2034, expanding at a CAGR of 9.0% over the forecast period. Growth is underpinned by the rising incidence of cerebrovascular disorders, expanding hospital and outpatient neurointervention infrastructure, and...